Beijing Tong Ren Tang Chinese Medicine Company Limited Stock OTC Markets
Equities
BJTRF
HK0000145638
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6484 USD | -56.77% |
|
-.--% | -56.48% |
Jun. 07 | Beijing Tong Ren Tang Chinese Medicine Company Limited Approves Final Dividend for the Year Ended December 31, 2023 | CI |
May. 13 | Tong Ren Tang Chinese Medicine Appoints CEO | MT |
Sales 2024 * | 1.74B 222M | Sales 2025 * | 1.99B 255M | Capitalization | 7.4B 948M |
---|---|---|---|---|---|
Net income 2024 * | 652M 83.5M | Net income 2025 * | 758M 97.08M | EV / Sales 2024 * | 2.63 x |
Net cash position 2024 * | 2.83B 363M | Net cash position 2025 * | 2.63B 337M | EV / Sales 2025 * | 2.4 x |
P/E ratio 2024 * |
11.4
x | P/E ratio 2025 * |
8.81
x | Employees | 798 |
Yield 2024 * |
4.52% | Yield 2025 * |
5.26% | Free-Float | 28.32% |
1 day | -56.77% | ||
3 months | -56.77% | ||
6 months | -56.48% | ||
Current year | -56.48% |
![Extreme 0.6484](/images/extremecours_fleche.png)
![Extreme 0.6484](/images/extremecours_fleche.png)
![Extreme 0.6484](/images/extremecours_fleche.png)
![Extreme 0.6484](/images/extremecours_fleche.png)
![Extreme 0.6484](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Fung Yi Tsang
DFI | Director of Finance/CFO | 48 | 12-09-30 |
Xia Li
CTO | Chief Tech/Sci/R&D Officer | 54 | 07-12-31 |
Fei Chen
BRD | Director/Board Member | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ngai Chi Chan
BRD | Director/Board Member | 52 | 13-04-14 |
Hai Ou Gu
CHM | Chairman | 58 | Dec. 12 |
Yok Sing Tsang
BRD | Director/Board Member | 76 | 17-09-11 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B |
- Stock Market
- Equities
- 3613 Stock
- BJTRF Stock